Author： Wysocki Piotr Jan
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.19, Iss.2, 2010-02, pp. : 265-274
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The Development of Targeted Therapies for Hepatocellular Cancer
Current Pharmaceutical Design, Vol. 13, Iss. 32, 2007-11 ,pp. :
Access to resources
Recommend
Endoglin-Targeted Cancer Therapy
Current Drug Delivery, Vol. 8, Iss. 1, 2011-01 ,pp. :
Targeted Therapy of Breast Cancer
Current Pharmaceutical Design, Vol. 13, Iss. 5, 2007-02 ,pp. :
Molecular Genetics and Targeted Therapy in Hepatocellular Carcinoma
Current Cancer Drug Targets, Vol. 16, Iss. 1, 2016-01 ,pp. :
Targeted therapy for epithelial ovarian cancer
Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 3, 2005-06 ,pp. :